# ClinicalTrials.gov record NCT00003124

> PeptideScanner retained ClinicalTrials.gov record NCT00003124 at 2026-07-30T21:54:46.538Z. Its registry update date was 2014-01-06, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct00003124-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-01-06
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00003124-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00003124-leuprolide-v1.json
- Content SHA-256: `2f739f3ccda6a40bf1980555db4ed77e6fde6eb1086270f78b62d874e29a2c7f`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00003124 ([`ctg-observation-nct00003124-2014-01-06-b1e0340b94b1`](#source-ctg-observation-nct00003124-2014-01-06-b1e0340b94b1))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00003124 at 2026-07-30T21:54:46.538Z. Its registry update date was 2014-01-06, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00003124-2014-01-06-b1e0340b94b1`](#source-ctg-observation-nct00003124-2014-01-06-b1e0340b94b1))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00003124 at 2026-07-30T21:54:46.538Z. Its registry update date was 2014-01-06, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00003124-2014-01-06-b1e0340b94b1`](#source-ctg-observation-nct00003124-2014-01-06-b1e0340b94b1))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00003124-2014-01-06-b1e0340b94b1`](#source-ctg-observation-nct00003124-2014-01-06-b1e0340b94b1))

## Sources

<a id="source-ctg-observation-nct00003124-2014-01-06-b1e0340b94b1"></a>
- **ClinicalTrials.gov record NCT00003124 · retained source version 2014-01-06:b1e0340b94b192f1df423f18a4bf353b55a29b88f60b1f231579785bab192fc6** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00003124) (`ctg-observation-nct00003124-2014-01-06-b1e0340b94b1`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00003124." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00003124-leuprolide-v1.json SHA-256: 2f739f3ccda6a40bf1980555db4ed77e6fde6eb1086270f78b62d874e29a2c7f.